{"id":237923,"date":"2026-09-09T13:25:56","date_gmt":"2026-09-09T07:55:56","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=237923"},"modified":"2026-09-09T13:25:56","modified_gmt":"2026-09-09T07:55:56","slug":"is-bodal-chemicals-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-bodal-chemicals-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Bodal Chemicals a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"

Bodal Chemicals share price around Rs 175. 6.0% below 52-week high of Rs 186. Q1 FY27 revenue Rs 715 crore, up 56.1% YoY. PAT Rs 30 crore, up 218.8%. PE 34x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Bodal Chemicals’ Q1 FY27 results were strong, with revenue at Rs 715 crore and PAT climbing 219% to Rs 30 crore. The stock trades at a PE of 34x against an industry average near 37x, which leaves room for a re-rating if this growth continues. The Bodal Chemicals share price near Rs 175 reflects that optimism, so investors weighing whether Bodal Chemicals is a good buy today should focus on whether this pace of growth can be sustained rather than just this quarter’s print.<\/p>\n<\/p><\/div>\n

The Bodal Chemicals share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Bodal Chemicals is a manufacturer of dyes, dye intermediates and chemical products, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 715 crore, up 56.1% year on year, while profit after tax came in at Rs 30 crore, up 218.8% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Bodal Chemicals share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Bodal Chemicals share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n